Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Clinical guideline on antibiotic prophylaxis for dental patients at risk for infection.

BIBLIOGRAPHIC SOURCE(S)

  • American Academy of Pediatric Dentistry (AAPD). Clinical guideline on antibiotic prophylaxis for dental patients at risk for infection. Chicago (IL): American Academy of Pediatric Dentistry (AAPD); 2005. 3 p. [6 references]

GUIDELINE STATUS

Note: This guideline has been updated. The National Guideline Clearinghouse (NGC) is working to update this summary.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Note: This guideline has been updated. The National Guideline Clearinghouse (NGC) is working to update this summary. The recommendations that follow are based on the previous version of the guideline.

Patients with Cardiac Conditions

Numerous cardiac conditions place patients at risk for endocarditis following dental manipulation. The American Academy of Pediatric Dentistry (AAPD) endorses the American Heart Association's (AHA) guideline on prevention of bacterial endocarditis. In addition to those diagnoses listed in the AHA guidelines, patients with a history of intravenous drug abuse and certain syndromes (e.g., Down, Marfan) may be at risk for developing bacterial endocarditis due to associated cardiac anomalies. The table below titled "Suggested Antibiotic Prophylactic Regimens," lists the suggested prophylaxis regimens.

Suggested Antibiotic Prophylactic Regimens*

Children not allergic to penicillin Amoxicillin 50 mg/kg (maximum 2 grams) orally 1 hour prior to dental procedure
Children not allergic to penicillin and unable to take oral medications Ampicillin 50 mg/kg (maximum 2 grams) intravenous (IV) or intramuscular (IM) within 30 minutes before dental procedure
Children allergic to penicillin Clindamycin 20 mg/kg (maximum 600 mg) orally 1 hour prior to dental procedure or Azithromycin 15 mg/kg (maximum 500 mg) orally 1 hour prior to procedure
Children allergic to penicillin and unable to take oral medications Clindamycin 20 mg/kg (maximum 600mg) IV or IM or Cefazolin 25 mg/kg (maximum 1gram) IV or IM within 30 min before dental procedure

*No second dose is recommended for any of these regimens. Adapted from: Dajani AS, Taubert KA, Wilson W, Bolger AF, et al. Prevention of bacterial endocarditis: Recommendations by the American Heart Association. JAMA. 1997;227:1794-1801.

Patients with Compromised Immunity

Patients with a compromised immune system may not be able to tolerate a transient bacteremia following invasive dental procedures. This category includes, but is not limited to, patients with the following conditions:

  1. Human immunodeficiency virus (HIV)
  2. Severe combined immunodeficiency syndrome (SCIDS)
  3. Neutropenia
  4. Immunosuppression
  5. Sickle cell anemia
  6. Status post splenectomy
  7. Chronic steroid usage
  8. Lupus erythematosus
  9. Diabetes
  10. Status post organ transplantation

Discussion of antibiotic prophylaxis for patients undergoing chemotherapy, irradiation, and hematopoietic cell transplantation appears in a separate AAPD guideline.

Patients with Shunts, Indwelling Vascular Catheters, or Medical Devices

Bacteremia following an invasive dental procedure may lead to colonization of shunts or indwelling vascular catheters. Vascular catheters, such as those required by patients undergoing dialysis, chemotherapy, or frequent administration of blood products, are susceptible to bacterial infections. Ventriculoatrial (VA) or ventriculovenus (VV) shunts for hydrocephalus are at risk of bacteremia-induced infections due to their vascular access. In contrast, ventriculoperitoneal (VP) shunts do not involve any vascular structures and, consequently, do not require antibiotic prophylaxis.

The AAPD endorses the recommendations of the American Dental Association and the American Academy of Orthopaedic Surgeons for management of patients with prosthetic joints. Antibiotic prophylaxis is not indicated for dental patients with pins, plates, and screws, nor is it indicated routinely for most dental patients with total joint replacements. Antibiotics may be considered when high-risk dental procedures (See table below titled "Dental Procedures Associated with Higher Incidence of Bacteremia") are performed for dental patients within 2 years following implant surgery or for patients who have had previous joint infections. Consultation with the child's physician may be necessary for management of patients with other implanted devices (e.g., Harrington rods, external fixation devices).

Dental Procedures Associated with Higher Incidence of Bacteremia

  • Dental extractions
  • Periodontal procedures including surgery, subgingival placement of antibiotics fibers/strips, scaling and root planning, probing, recall maintenance
  • Dental implant placement and replantation of avulsed teeth
  • Endodontic instrumentation or surgery only beyond the apex
  • Initial placement of orthodontic bands but not brackets
  • Intraligamentary and intraosseous local anesthetic injections
  • Prophylactic cleaning of teeth or implants where bleeding is anticipated

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

All oral health policies and clinical guidelines are based on 2 sources of evidence: (1) the scientific literature; and (2) experts in the field.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • American Academy of Pediatric Dentistry (AAPD). Clinical guideline on antibiotic prophylaxis for dental patients at risk for infection. Chicago (IL): American Academy of Pediatric Dentistry (AAPD); 2005. 3 p. [6 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2002 (revised 2005)

GUIDELINE DEVELOPER(S)

American Academy of Pediatric Dentistry - Professional Association

SOURCE(S) OF FUNDING

American Academy of Pediatric Dentistry

GUIDELINE COMMITTEE

Council on Clinical Affairs

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Not stated

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

Note: This guideline has been updated. The National Guideline Clearinghouse (NGC) is working to update this summary.

GUIDELINE AVAILABILITY

Electronic copies of the updated guideline: Available from the American Academy of Pediatric Dentistry Web site.

Print copies: Available from the American Academy of Pediatric Dentistry, 211 East Chicago Avenue, Suite 700, Chicago, Illinois 60611

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI on August 18, 2005.

COPYRIGHT STATEMENT

This summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo